Intellia Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress

Go back to Intellia Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress
(NASDAQ: NTLA) Delayed: 12.69 +0.47 (3.85%)
Previous Close $12.22    52 Week High $30.40 
Open $12.27    52 Week Low $11.86 
Day High $12.97    P/E N/A 
Day Low $12.14    EPS $0.00 
Volume 3,921,408